Skip to content
OpenCapital
Get started

QuidelOrtho Corporation QDEL R&D

R&D at other companies

Haemonetics logo
HaemoneticsHAE
$8.46M-6.2%
Abbott logo
AbbottABT
$444M+10.7%
Bausch + Lomb logo
Bausch + LombBLCO
$13M+18.2%
ServiceNow logo
ServiceNowNOW
$823M+17.1%
Abbott logo
AbbottABT
$155M+2.6%
Opko Health logo
Opko HealthOPK
$312K-42.0%

Segments

By segment

See full
China$700K-22.2%
Latin America$500K+25.0%
EMEA$400K-33.3%
North America$400K0.0%
JPAC$300K-25.0%

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$832.61M-56.1%
Enterprise value$3.8B-22.0%
P/S0.3×-0.4×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%—

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept qdel:SegmentInformationResearchAndDevelopmentExpense.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's R&D?
QuidelOrtho Corporation (QDEL) reported R&D of $2.3M in Q1 2026.
How has QuidelOrtho Corporation's R&D changed year-over-year?
QuidelOrtho Corporation's R&D decreased by 14.8% year-over-year, from $2.7M to $2.3M.
What is the long-term trend for QuidelOrtho Corporation's R&D?
Over 2 years (2023 to 2025), QuidelOrtho Corporation's R&D has grown at a -4.4% compound annual growth rate (CAGR), from $11.7M to $10.7M.
What does R&D mean?
The total investment in activities aimed at discovering, developing, or improving diagnostic products and technologies. This reflects the company's commitment to innovation and its long-term strategy for maintaining a competitive edge in the medical device market.